# Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers

> **NCT04626895** · NA · COMPLETED · sponsor: **Medstar Health Research Institute** · enrollment: 15 (actual)

## Conditions studied

- Breast Cancer
- Ovarian Cancer
- Gynecologic Neoplasm
- Endometrial Cancer

## Interventions

- **DEVICE:** Paxman Scalp Cooling Device

## Key facts

- **NCT ID:** NCT04626895
- **Lead sponsor:** Medstar Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-04
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-10-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04626895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04626895, "Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04626895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*